AIM ImmunoTech (AIM) Return on Equity (ROE) (2006 - 2026)
AIM ImmunoTech (AIM) Return on Equity (ROE) from Jan 31, 2006 to Mar 31, 2026. The TTM AIM ImmunoTech (AIM) Return on Equity (ROE) is -142.26%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual ROE
Quarterly ROE
Annual Return on Equity (ROE) change of AIM ImmunoTech (AIM)
| Year | Return on Equity (ROE) | Change |
|---|---|---|
| 2025 | 142.74% | -89.12% |
| 2024 | 1312.12% | -563.50% |
| 2023 | -283.09% | +460.21% |
| 2022 | -50.53% | +50.25% |
| 2021 | -33.63% | +43.15% |
| 2020 | -23.49% | -67.73% |
| 2019 | -72.81% | -61.63% |
| 2018 | -189.75% | +99.86% |
| 2017 | -94.94% | +96.21% |
| 2016 | -48.39% | -35.28% |
| 2015 | -74.77% | +7.12% |
| 2014 | -69.80% | +26.01% |
| 2013 | -55.39% | +42.71% |
| 2012 | -38.81% | +63.57% |
| 2011 | -23.73% | -17.02% |
| 2010 | -28.60% | +24.90% |
| 2009 | -22.90% | -78.38% |
| 2008 | -105.89% | +22.35% |
| 2007 | -86.55% | +10.41% |
| 2006 | -78.38% | N/A |